Independent Healthcare Providers Network

iHealthScreen Inc. Announces UK Medicines and Healthcare Products Regulatory Agency (MHRA) Certification and registration for iPredict™ - Automated AI System for Early Diagnosis of DR, AMD, and Glaucoma

Retrieved on: 
Tuesday, December 5, 2023

iPredict™ AI Eye Screening System provides fully automated diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results.

Key Points: 
  • iPredict™ AI Eye Screening System provides fully automated diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results.
  • The entire test can easily and reliably be completed within 5 minutes.
  • iPredict-AMD can detect referable AMD such as intermediate to late AMD and non-referable AMD such as early or none.
  • iPredict is indicated for use by healthcare providers in clinics, hospitals, or other healthcare facilities to automatically detect DR, AMD, and glaucoma suspects.

Across Washington, Amerigroup to be Renamed Wellpoint in January 2024

Retrieved on: 
Monday, November 13, 2023

Amerigroup, a subsidiary of Elevance Health serving Apple Health (Medicaid) and Medicare enrollees, will begin rebranding as Wellpoint Washington, Inc. (Wellpoint ) in January 2024, to reflect the company’s evolution to support whole health.

Key Points: 
  • Amerigroup, a subsidiary of Elevance Health serving Apple Health (Medicaid) and Medicare enrollees, will begin rebranding as Wellpoint Washington, Inc. (Wellpoint ) in January 2024, to reflect the company’s evolution to support whole health.
  • Members will continue to have access to their established primary care providers, specialists, hospitals and other healthcare facilities.
  • Also, healthcare providers who serve Wellpoint members will have continued access to tools and resources to help streamline day-to-day administrative tasks.
  • Members can continue using their current Amerigroup card to access all existing services through the end of 2023.

Cardiovascular Ultrasound Market to Reach $4.2 Billion by 2032, exhibiting a CAGR of 5.8% from 2023 to 2032: Allied Market Research

Retrieved on: 
Wednesday, December 6, 2023

PORTLAND, Ore., Dec. 6, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Cardiovascular Ultrasound Market by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, and Others), Technology (2D, 3D & 4D, and Others), Display Type (Color and Black & White), and End User (Hospital, Cardiac Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global cardiovascular ultrasound market was valued for $2.4 Billion in 2022, and is projected to reach $4.2 Billion by 2032, registering a CAGR of 5.8% from 2023 to 2032.

Key Points: 
  • The 2D segment to maintain its leadership status throughout the forecast period.
  • However, the cardiac centers segment is projected to manifest a significant CAGR of 6.4% from 2023 to 2032.
  • Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global cardiovascular ultrasound market revenue.
  • This is attributed to high presence of cardiovascular ultrasound drug manufacturers in North America and rising prevalence of chronic disease such as cancer and chronic pain.

Cardiovascular Ultrasound Market to Reach $4.2 Billion by 2032, exhibiting a CAGR of 5.8% from 2023 to 2032: Allied Market Research

Retrieved on: 
Wednesday, December 6, 2023

PORTLAND, Ore., Dec. 6, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Cardiovascular Ultrasound Market by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, and Others), Technology (2D, 3D & 4D, and Others), Display Type (Color and Black & White), and End User (Hospital, Cardiac Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global cardiovascular ultrasound market was valued for $2.4 Billion in 2022, and is projected to reach $4.2 Billion by 2032, registering a CAGR of 5.8% from 2023 to 2032.

Key Points: 
  • The 2D segment to maintain its leadership status throughout the forecast period.
  • However, the cardiac centers segment is projected to manifest a significant CAGR of 6.4% from 2023 to 2032.
  • Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global cardiovascular ultrasound market revenue.
  • This is attributed to high presence of cardiovascular ultrasound drug manufacturers in North America and rising prevalence of chronic disease such as cancer and chronic pain.

Health Cover UK Market Report Reveals Rising Demand for Private Health Coverage - ResearchAndMarkets.com

Retrieved on: 
Friday, October 27, 2023

The "Health Cover UK Market Report 18ed" report has been added to ResearchAndMarkets.com's offering, which highlights the surging demand for private health care in the UK.

Key Points: 
  • The "Health Cover UK Market Report 18ed" report has been added to ResearchAndMarkets.com's offering, which highlights the surging demand for private health care in the UK.
  • The Health Cover UK Market Report, now in its 18th edition, provides essential insights into the rebounding health cover market, proving indispensable for business entrepreneurs and managers in navigating this evolving landscape.
  • With the health cover market now valued at an impressive £6.2 billion, the report chronicles a notable resurgence in demand for private health coverage, primarily attributed to extended waits for NHS treatment.
  • To acquire the Health Cover UK Market Report and gain unparalleled insights into the future of the UK's health coverage sector, visit https://www.researchandmarkets.com/r/74sbj9

GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste for Healthcare Providers

Retrieved on: 
Thursday, October 26, 2023

GE HealthCare (Nasdaq: GEHC) and reLink Medical today announced a collaboration to deliver asset management solutions to healthcare providers to help reduce medical device waste, increase operational efficiency and maximize their equipment utilization.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) and reLink Medical today announced a collaboration to deliver asset management solutions to healthcare providers to help reduce medical device waste, increase operational efficiency and maximize their equipment utilization.
  • “A potential and often overlooked source of expense for providers is medical device waste, which includes aging, or end-of-life, medical devices that sit idle in a healthcare provider’s inventory,” said Mohamed El-Demerdash, President, U.S. & Canada Service, GE HealthCare.
  • More than six million pounds of medical waste are kept out of landfills each year through reLink Medical’s processes.3 This collaboration between GE HealthCare and reLink Medical is aimed at supporting healthcare providers in disposing medical equipment in a safe, compliant and environmentally responsible manner and it further advances GE HealthCare and reLink Medical’s commitment to sustainability.
  • “It leverages reLink Medical’s expertise in equipment disposition, surplus management and inventory optimization to complement GE HealthCare’s comprehensive suite of healthcare solutions.”
    1 reLink Medical data on file.

Connected Medication Compliance Monitoring Devices Surge to 4.4 Million Units in 2022, Set to Reach 8.2 Million Units by 2027: New Report Reveals Remarkable Market Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, October 23, 2023

The Medication Compliance Monitoring Market is a new report that provides insights into the adoption of wireless solutions aimed at helping patients improve medication adherence.

Key Points: 
  • The Medication Compliance Monitoring Market is a new report that provides insights into the adoption of wireless solutions aimed at helping patients improve medication adherence.
  • Market Growth: There were 4.4 million connected medication compliance monitoring devices in use worldwide at the end of 2022.
  • Solutions: Medication compliance monitoring solutions encompass a range of devices and services, including injected medication solutions, inhaled medication solutions, pill bottles, and dispensers.
  • Who are the leading providers of connected medication compliance monitoring devices?

Global Cybersecurity Leader eSentire Extends its Award-Winning 24/7 Security Operations Center as a Service (SOCaaS) Protection to Organizations Across the United Arab Emirates

Retrieved on: 
Monday, October 16, 2023

GITEX GLOBAL-- eSentire , the Authority in Managed Detection and Response (MDR), today announced it has extended its award-winning, 24/7 Security Operations Center as a Service (SOCaaS) protection across the United Arab Emirates (UAE), adhering to federal data compliance requirements and prioritizing localized cybersecurity service support.

Key Points: 
  • GITEX GLOBAL-- eSentire , the Authority in Managed Detection and Response (MDR), today announced it has extended its award-winning, 24/7 Security Operations Center as a Service (SOCaaS) protection across the United Arab Emirates (UAE), adhering to federal data compliance requirements and prioritizing localized cybersecurity service support.
  • In its July 2023 Worldwide Leadership Compass Report , KuppingerCole also named eSentire the Overall Leader for Managed Detection and Response, as well as Product Leader, Innovation Leader and Market Leader.
  • Most recently, eSentire was named CrowdStrike’s 2-time Global MSSP of the Year (22, 23) recognizing that more organizations globally choose eSentire to manage CrowdStrike EDR than any other service provider.
  • “We are excited to be extending our award-winning SOCaaS capabilities with localized support in the UAE,” said Bob Layton, eSentire Chief Channel Officer.

Cinfa Participates in the 34th Annual Conference of the SHA

Retrieved on: 
Thursday, October 12, 2023

Cinfa, the leading Spanish pharmaceutical company, participates as a high-level partner in the 34th Annual Conference of the Saudi Heart Association (SHA), which will take place from the 12th to the 14th of October in the Crowne Plaza RDC Riyadh- Saudi Arabia.

Key Points: 
  • Cinfa, the leading Spanish pharmaceutical company, participates as a high-level partner in the 34th Annual Conference of the Saudi Heart Association (SHA), which will take place from the 12th to the 14th of October in the Crowne Plaza RDC Riyadh- Saudi Arabia.
  • View the full release here: https://www.businesswire.com/news/home/20231012941071/en/
    CINFA PARTICIPATES IN THE 34th ANNUAL CONFERENCE OF THE SHA (Photo: Business Wire)
    The Saudi Heart Association’s 34th annual conference aims to encompass the theme “Population Health from Prevention to Intervention”, to talk about the importance and effectiveness of interventions that engage community health workers to prevent cardiovascular disease and aim to reduce risk factors among those at higher risk by providing culturally appropriate education, offering social support counseling, and connecting people with services.
  • SHA’s mission is to set international healthcare standards for diagnosing and treating cardiovascular disease in Saudi Arabia.
  • Cinfa currently partners with more than 8,500 medical centres and pharmacies in Saudi Arabia, Qatar, the United Arab Emirates and Kuwait.

White-label solution differentiators that help organizations stay ahead of the curve

Retrieved on: 
Thursday, October 12, 2023

Brands turn to white-label solutions for various reasons, as well as allow them to focus on their core competencies.

Key Points: 
  • Brands turn to white-label solutions for various reasons, as well as allow them to focus on their core competencies.
  • By leveraging existing solutions, brands can save on research, development, and infrastructure expenses, making it an attractive option.
  • Built for Scale: White-label solutions are customizable to cater to the specific needs of different partners.
  • From a dynamic multi-funnel approach to personalized loyalty features, seamless mobile compatibility, and an unbeatable inventory, Rocket Travel by Agoda's white-label solution harnesses the power of technology to help partner brands' stay ahead of the curve.